VPA also inhibited the proliferation of SHSY5Y neuroblastoma (NB) cancer cells in a time- and dose-dependent manner by downregulating URG4/URGCP and its transcriptional target CCND1, leading, in turn, to cell cycle arrest [222]. The gene discussed is URGCP; the disease is neuroblastoma.